Drugmaker GlaxoSmithKline (GSK)’s chief executive officer Andrew Witty on Tuesday unveiled the company’s plans to allow “free access to its library of 13,500 potential malaria treatments and devote the profits from its experimental [RTS,S] vaccine to battling tropical illnesses that beset poor countries,” Bloomberg reports (Randall, 1/20).
Scientists Determine How Malaria Parasite Enters Body Scientists have discovered how the malaria parasite enters the body, ABC Science reports. The researchers, who describe their findings in the journal Cell Host & Microbe, say that by better understanding the basic biology of how parasites move can help in the development…
Canadian Health Minister Leona Aglukkaq on Wednesday announced plans for the country to loan Mexico five million doses of the H1N1 (swine flu) vaccine, Agence France-Presse reports. The loan will help Mexico meet its innoculation demand, while the country waits for H1N1 vaccine orders to be fulfilled by several manufacturers.
Amid recent complaints that the WHO exaggerated the threat of the H1N1 (swine flu) virus, the agency announced Tuesday an upcoming independent review of the agency’s handling of the pandemic, Agence France-Presse reports (1/12).
In his second annual letter, Bill Gates reflects on the Bill & Melinda Gates Foundation’s work and the importance innovation will play in overcoming some of the world’s greatest challenges, including in global health and agriculture, the Associated Press/Wall Street Journal reports. “Gates says the foundation currently is backing 30 areas of innovation including online learning, teacher improvement, malaria vaccine development, HIV prevention, and genetically modified seeds,” according to the news service (1/25).
As the number of H1N1 (swine flu) cases in the U.S. continues to wane, the New York Times reflects on how federal officials handled the pandemic and other contributing factors. “The outbreak highlighted many national weaknesses: old, slow vaccine technology; too much reliance on foreign vaccine factories; some major hospitals pushed to their limits by a relatively mild epidemic,” the newspaper writes.
Lancet Series Papers Examine Surveillance, Economic Impact Of NTDs “As national programmes respond to the new opportunities presented for scaling up preventive chemotherapy programmes for the coadministration of drugs to target [several neglected tropical diseases (NTDs)] possible synergies between existing disease-specific policies and protocols need to be examined,” write the…
Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports. Fukuda’s defense came amid reports this week that the Council of Europe will investigate the WHO’s actions and as several countries slash H1N1 vaccine orders.
Agence France-Presse examines the WHO’s response to H1N1 (swine flu) one year since the virus was first reported in Mexico and the U.S. “A year on, questions linger as to whether a decision by the World Health Organization to declare swine flu a pandemic, thereby unleashing the slew of health measures, was over-dramatic or even tainted by commercial interests,” the news service writes.
Also In Global Health News: Iraq’s Health System; HIV Travel Restrictions; India Cholera Vaccine; HIV/AIDS Prevention In Indonesia; U.S. Federal Quarantine Regulations
IRIN Examines ‘Long And Complicated’ Process To Developing Iraq’s Health System IRIN examines how decades of conflict in Iraq have stymied development of the country’s health system. The piece includes comments by Iraqi Health Minister Salih al-Hasnawi, who describes the process of “developing [the country's health facilities] to reach international…